Results 81 to 90 of about 4,638,258 (384)

The “abuse of right” in EU company law and EU tax law: A re-reading of the ECJ case-law and the quest for a unitary notion [PDF]

open access: yes, 2010
This article discusses whether, in light of the developments of the ECJ case-law in different areas, and in particular in the areas of EU company law and EU tax law, it is possible to identify a unitary concept of “abuse of rights” in EU law, and whether
Cerioni, L
core  

The European Model Company Law Act project [PDF]

open access: yes, 2008
On 27 and 28 September 2007, a commission formed on the initiative of the authors held its first meeting in Aarhus, Denmark to deliberate on its goal of drafting a "European Model Company Law Act" (EMCLA).
Baums, Theodor, Krüger Andersen, Paul
core   +1 more source

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang   +4 more
wiley   +1 more source

In search of transparency for EU law-making: Trilogues on the cusp of dawn

open access: yesCommon market law review, 2017
Who controls the information that is part of the EU legislative processes and is the process as a whole under control? This article explores the legal framework and the applicability of that framework to evolving informal practices by the three key ...
D. Curtin, P. Leino
semanticscholar   +1 more source

Virtual or In‐Person: Does It Matter? Comparing Pain, Function, Quality of Life, Self‐Efficacy, and Physical Function Outcomes of Virtual, Hybrid, and In‐Person Education and Exercise Program Participants

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to determine if program format (in‐person, virtual, or hybrid) results in differences in 3‐month outcomes of pain, function, quality of life, self‐efficacy, and chair stands in a hip/knee osteoarthritis‐management program. Methods A secondary analysis of the Good Life with osteoArthritis in Denmark (GLA:D) Canada database was
Jill Van Damme   +7 more
wiley   +1 more source

THE IMPLICATIONS OF THE EU AI ACT ON CONVERSATIONAL TECHNOLOGIES LIKE CHATGPT [PDF]

open access: yesChallenges of the Knowledge Society
This paper investigates the implications of the European Union's Artificial Intelligence Act (AI Act), on conversational AI technologies. As the EU institutes a groundbreaking framework for AI regulation, this study assesses how the AI Act's risk ...
Emilian MATEICIUC
doaj  

Why is a European Law on Disability Discrimination important [PDF]

open access: yes, 2001
EU law offers great potential for advancing the rights and interests of disabled people living within the European Union, but this potential is yet to be fully realised.
Whittle, R.
core  

Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically Active

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to identify in patients with systemic lupus erythematosus (SLE) with clinically active disease the attainment of frequency and determinants of Lupus Low Disease Activity State (LLDAS) and Definition of Remission in SLE (DORIS) and the frequency and determinants of flare and damage accrual after target attainment.
Yanjie Hao   +39 more
wiley   +1 more source

The Impact of EU Enlargement on the Russian Federation [PDF]

open access: yesRomanian Journal of European Affairs, 2004
EU Enlargement is a consequence of the success story of the creation of the European Communities, as many applicant countries were attracted to the new legal order based on the rule of law, rather than to an order or disorder based on the rule of ...
Alfred E. Kellermann
doaj  

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and One‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

open access: yesArthritis Care &Research, Accepted Article.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy